Please provide your email address to receive an email when new articles are posted on . New-onset atrial fibrillation and atrial flutter are as common in hospitalized patients with influenza as with ...
VIENNA, November 27, 2024--(BUSINESS WIRE)--AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration (FDA) has granted regulatory ...
Approval was based on the combined results from five studies of adults with supraventricular tachycardia. The FDA has approved AOP Health’s Rapiblyk (landiolol) for the rapid management of atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback